Unusual Options Activity in Dell Technologies Inc. (DELL)
Today, among the underlying components of the NYSE, we saw additional unusual or noteworthy options trading volume and activity in Dell Technologies Inc. (DELL), which opened at $100.21.
There were a total of 5,000 contracts traded on the $95 strike put option at the bid, dated for December 17th, 2021, representing approximately 500,000 shares.
Additionally, there were another 5,000 contracts traded on the $95 strike put option also at the bid, dated for October 15th, 2021, representing an additional 500,000 shares.
Finally, there was another final set of 5,000 contracts traded on the $90 strike put option also at the bid, dated for December 17th, 2021, representing another 500,000 shares.
Unusual Options Activity in Constellium SE (CSTM)
Today, among the underlying components of the NYSE, we saw unusual or noteworthy options trading volume and activity in Constellium SE (CSTM), which opened at $20.65.
There were a total of 6,250 contracts traded on the $18 strike put option at the bid, dated for October 22nd, 2021, representing approximately 625,000 shares. Additional subsequent orders of smaller lot sizes were found this morning with the Unusual Whales Flow on the 21 strike put option, also at the bid, for the same date.
These orders come after a report listing Constellium SE (CSTM) one of the 7 aluminum stocks to buy even as prices hit decade highs.
Unusual Options Activity in Merck & Co., Inc. (MRK)
Finally, among the underlying components of the NYSE, we saw unusual or noteworthy options trading volume and activity today in Merck & Co., Inc. (MRK), which opened at $73.02.
There were a total of 15,000 contracts traded on the $75 strike call option at the ask, dated for December 17th, 2021, representing approximately 1,500,000 shares.
Additionally, there was another set of 10,000 contracts traded on the $65 strike put option at the ask, also dated for December 17th, 2021, representing approximately 1,000,000 shares.
These orders come after French medical devices maker BIOCORP announced Thursday an agreement with Merck & Co., Inc. (MRK) for the development and supply of a specific version of Mallya device to monitor treatment adherence in the field of Human Growth Hormone or HGH.
For further information on the unusual options activity of DELL, CSTM, and MRK visit unusualwhales.com.
For more information on unusual options activity, subscribe to the Unusual Blog or visit unusualwhales.com.